Search results
Q1 2023 Fate Therapeutics Inc Earnings Call
Thomson Reuters StreetEvents via Yahoo Finance· 12 months agoParticipants Bahram Valamehr; Chief Research & Development Officer; Fate Therapeutics, Inc. Edward J. Dulac; CFO; Fate Therapeutics, Inc. J. Scott Wolchko; Founder, CEO, President & Director ...
Arrowhead Pharmaceuticals Inc Reports Fiscal 2023 Year-End Results
GuruFocus.com via Yahoo Finance· 5 months agoArrowhead Pharmaceuticals Inc (NASDAQ:ARWR) announced a net loss of $205.3 million for the fiscal...
Q3 2023 Legend Biotech Corp Earnings Call
Thomson Reuters StreetEvents via Yahoo Finance· 5 months agoParticipants Guowei Fang; Chief Scientific Officer & Head of Business Development; Legend Biotech Corporation Jessie Yeung Lori A. Macomber; CFO; Legend Biotech Corporation Steven J. Gavel; ...
Fate Therapeutics, Inc. (NASDAQ:FATE) Q4 2022 Earnings Call Transcript
Insider Monkey via Yahoo Finance· 1 year agoFate Therapeutics, Inc. (NASDAQ:FATE) Q4 2022 Earnings Call Transcript February 28, 2023 Operator:...
Bristol Myers (BMY) Thrombosis Drug Gets Fast Track Designation
Zacks via Yahoo Finance· 11 months agoBristol Myers (BMY) obtains Fast Track Designation from the FDA for milvexian, which is being...
MeiraGTx Holdings PLC Reports Q3 2023 Financial Results and Operational Progress
GuruFocus.com via Yahoo Finance· 6 months agoMeiraGTx Holdings PLC (NASDAQ:MGTX) announces Q3 2023 financial results with a net loss of $44.3...
MeiraGTx Holdings PLC Reports Notable Clinical Progress Amidst Financial Challenges in 2023
GuruFocus.com via Yahoo Finance· 2 months agoCash Position: Cash and cash equivalents increased to $129.6 million as of December 31, 2023, from $115.5 million the previous year. License Revenue: License revenue decreased slightly to $14.0 ...
New Lenawee County community development coordinator hits the ground running
The Daily Telegram via Yahoo News· 12 months agoADRIAN — Lenawee County has a new community development coordinator, and she is already hard at work...
If Sanofi Opted For Takeover Of Horizon Therapeutics, It Would Be In Cash
Benzinga via Yahoo Finance· 1 year agoSanofi (NASDAQ: SNY) said that if it ever bid for biotech company Horizon Therapeutics Public...
Two Down With Sanofi Bowing Out From Horizon Buyout Talks, Amgen Agrees To Buy For $116.5/Share
Benzinga via Yahoo Finance· 1 year agoAmgen Inc (NASDAQ: AMGN) has agreed to buy Horizon Therapeutics plc (NASDAQ: HZNP), implying an...
